Medical Device
Filter News
Found 13,819 articles
-
Eko Launches ‘Eko Home,' a Cardiac Remote Monitoring Application Enabling Powerful Drug-Data Combinations to Enhance Clinical Studies and Pharmaceutical Trials
7/25/2019
Eko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced Eko Home, a first-of-its-kind service that enables precise remote monitoring of cardiac function using ECG and heart sounds
-
Orthofix Schedules Second Quarter 2019 Earnings Release and Conference Call for August 5, 2019
7/25/2019
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarter 2019 after market close on Monday, August 5, 2019.
-
The All-New Soberlink Connect Device Delivers Improved Performance in Both Design and Functionality
7/25/2019
Soberlink introduces the all-new Soberlink Connect Device that packs the latest alcohol monitoring technology into a smaller, lighter, and faster device.
-
Covalon CEO Provides Corporate Update
7/25/2019
Covalon Technologies Ltd., an advanced medical technologies company, wishes to provide the following corporate update
-
Nevro Announces Court Order Granting Preliminary Injunction Against Stimwave Technologies, Inc.
7/25/2019
Nevro Corp. announced that U.S. District Judge Colm Connolly, in the District of Delaware, granted Nevro's motion for preliminary injunction, and has issued an order barring Stimwave Technologies, Inc., and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz by programming Stimwave's SCS systems to deliver its recently introduced high-frequency, paresthesia-free SCS therapy.
-
PathMaker Neurosystems Announces Publication of First Clinical Trial Results for its MyoRegulator® Device for Non-Invasive Treatment of Spasticity
7/25/2019
PathMaker Neurosystems Inc., a clinical-stage bioelectronic medicine company developing breakthrough non-invasive systems for the treatment of patients with spasticity and paralysis announces the first publication of clinical trial results for its MyoRegulator® device for the non-invasive treatment of spasticity.
-
Life Spine Announces FDA 510(k) Clearance of the PROLIFT® Expandable Spacer System In 8mm-10mm Widths
7/25/2019
As opposed to traditional static interbodies, PROLIFT was engineered to reduce the need for surgical steps, such as sequential trialing, and in turn reduce operating time.
-
FDB to Demonstrate How Enhanced Medical Device Data Can Support CQO Movement at AHRMM Conference 2019
7/25/2019
Patrick Lupinetti to share how Augmented Unique Device Identifier (AUDI) information on coronary artery stents provided by FDB can be used to enhance surgical point-of-care and outcomes studies
-
Life Spine's Statement Pertaining to Civil Litigation With Manhattan U.S. Attorney
7/25/2019
Life Spine, Inc., a medical device manufacturer dedicated to improving the quality of life for spinal patients, has recently become aware of a series of allegations made in a civil complaint filed by the U.S. Attorney’s Office in the Southern District of New York.
-
Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019
7/25/2019
Corindus Vascular Robotics, Inc. announced that it will release second quarter 2019 financial and business results on Thursday, August 8, 2019 before the open of the U.S. financial markets.
-
Senseonics to Participate in the Canaccord Genuity Growth Conference - July 25, 2019
7/25/2019
Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, announced the company plans to participate in the upcoming Canaccord Genuity Growth Conference in Boston, MA.
-
BrainScope Surpasses Primary Endpoints in Multi-Year Department of Defense-Funded Validation Study for New Concussion Assessment Capability
7/25/2019
BrainScope announced that it has successfully completed a nearly five year, $9.9 million U.S. Department of Defense research contract supporting the development and validation of an objective marker of the presence and severity of concussion.
-
Laminate Medical Technologies announces enrollment of first forearm patients in pivotal trial of the VasQ device
7/24/2019
Laminate Medical Technologies (Laminate) has announced the enrollment of their first forearm fistula patients in their US pivotal trial of the VasQ™ device.
-
Children's National 7th Annual Pediatric Device Innovation Symposium features $150K NICU pitch competition and explores clinical trial process
7/24/2019
The Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System announces its 7th Annual Pediatric Device Innovation Symposium is slated for Sunday, Sept. 22 in Boston, Mass., featuring a $150K medical device competition focused on innovations for neonatal and NICU care.
-
Insulet to Present at Upcoming Investor Conferences - July 24, 2019
7/24/2019
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced that management will present at three upcoming investor conferences
-
Hardy Diagnostics Releases New Room Temperature Storage Sterile Environmental Monitoring Plates
7/23/2019
Hardy Diagnostics has begun production of triple-bagged, irradiated SterEM™ mono plates and Lok-Tight™ irradiated contact plates with new package enhancements.
-
Soliton's FDA Cleared Device is Granted Key Patent
7/23/2019
European Patent Office Approves Core Patent Covering Soliton's RAP Technology
-
AngioDynamics to Present at the Canaccord Genuity Growth Conference
7/23/2019
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, will present at the 39th Annual Canaccord Genuity Growth Conference at 10:30 a.m. ET on Wednesday, August 7, 2019 in Boston, MA.
-
Apollo Endosurgery, Inc. Reports Second Quarter 2019 Results
7/23/2019
Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2019.
-
Global Medical Device Vigilance Market to Surpass US$ 99.2 Billion by 2026
7/23/2019
According to Coherent Market Insights, the global medical device vigilance market was valued at US$ 53.4 billion in 2018, and is projected to exhibit a CAGR of 8.1% during the forecast period (2019 – 2026).